- Celebrities Share Their Breast Cancer Stories.
- [No author given]
- My Gene Counsel. Genetic Journal. 2020 Oct 7.
- Blog post
- Free Full Text
Category: General
- Advances in epithelial ovarian cancer.
- Neesham D, Richards A, McGauran M.
- Aust J Gen Pract. 2020 Oct;49(10):665-669.
- PMID: 33015682
- PubMed abstract
- Review
- Free Full Text
- Bioethics and healthcare policies. The benefit of using genetic tests of BRCA 1 and BRCA 2 in elderly patients.
- Fonseca V, Caeiro J.
- Int J Health Plann Manage. 2020 Sep 25. doi: 10.1002/hpm.3072. Epub ahead of print.
- PMID: 32978840
- PubMed abstract
- Source abstract
- Commentary
- Who Should Consider BRCA Testing?
- [No author given]
- My Gene Counsel. Genetic Journal Blog. 2020 Sep 24.
- Blog post
- Free Full Text
- Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.
- Green RF, Kumerow MT, Rodriguez JL, Addie S, Beachy SH, Senier L.
- Public Health Genomics. 2020 Sep 17:1-12. doi: 10.1159/000510336. Epub ahead of print.
- PMID: 32942283
- PubMed abstract
- Source abstract
Original research:
Proposed outcomes measures for state public health genomic programs.
- PMID: 29300382
- PubMed abstract
- Free Full Text
- Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.
- Green RF, Kumerow MT, Rodriguez JL, Addie S, Beachy SH, Senier L.
- Public Health Genomics. 2020 Sep 17:1-12. doi: 10.1159/000510336. Epub ahead of print.
- PMID: 32942283
- PubMed abstract
- Source abstract
Original research:
Proposed outcomes measures for state public health genomic programs.
- PMID: 29300382
- PubMed abstract
- Free Full Text
- Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes.
- Pietragalla A, Arcieri M, Marchetti C, Scambia G, Fagotti A.
- Int J Gynecol Cancer. 2020 Sep 6:ijgc-2020-001556. doi: 10.1136/ijgc-2020-001556. Epub ahead of print.
- PMID: 32895312
- PubMed abstract
- Source abstract
- Review
- Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis.
- Yoshida R.
- Breast Cancer. 2020 Aug 29. doi: 10.1007/s12282-020-01148-2. Epub ahead of print.
- PMID: 32862296
- PubMed abstract
- Review
- Free Full Text
- An overview of cancer genetics with focus on involvement of BRCA1/2 genes in breast carcinomas.
- Tahir DE, Rehman MS, Rehman MU.
- J Pak Med Assoc. 2020 Jul;70(7):1240-1247. doi: 10.5455/JPMA.20351.
- PMID: 32799280
- PubMed abstract
- Review
- Free Full Text
LitAlert ~~ GeneLit.com
- Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic VariantsResults From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
- Silvestri V, Leslie G, Barnes DR, the CIMBA Group.
- JAMA Oncol. 2020 Jul 2. doi: 10.1001/jamaoncol.2020.2134. [Epub ahead of print]
- Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives.
- Cocco S, Piezzo M, Calabrese A, Cianniello D, Caputo R, Lauro VD, Fusco G, Gioia GD, Licenziato M, Laurentiis M.
- Int J Mol Sci. 2020 Jun 27;21(13):E4579. doi: 10.3390/ijms21134579.
- PMID: 32605126
- PubMed abstract
- Source abstract
- Review
- Free Full Text